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SUMMARY

1Department

Nucleocapsid (N) encoded by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) plays key roles in the replication cycle and is a critical serological
marker. Here, we characterize essential biochemical properties of N and describe
the utility of these insights in serological studies. We define N domains important
for oligomerization and RNA binding and show that N oligomerization provides a
high-affinity RNA-binding platform. We also map the RNA-binding interface,
showing protection in the N-terminal domain and linker region. In addition, phosphorylation causes reduction of RNA binding and redistribution of N from liquid
droplets to loose coils, showing how N-RNA accessibility and assembly may be
regulated by phosphorylation. Finally, we find that the C-terminal domain of N
is the most immunogenic, based on antibody binding to patient samples.
Together, we provide a biochemical description of SARS-CoV-2 N and highlight
the value of using N domains as highly specific and sensitive diagnostic markers.
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Cité, Paris, France

5Department

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus and the causative
agent of coronavirus disease 2019 (COVID-19). The coronavirus has a single-stranded, positive-sense
RNA genome encoding for four major structural proteins: spike (S), envelope (E), membrane (M), and nucleocapsid (N). The N protein is the second-most proximal to the 30 end of the genome and is one of the most
abundantly expressed viral proteins given the multifunctional roles of N during viral replication and assembly (Fung and Liu, 2019; Kim et al., 2020; McBride et al., 2014; Perlman and Netland, 2009). It is estimated
that 1,000 copies of N are incorporated into each virion compared with only 100 copies of S (Bar-On et al.,
2020). N exists mostly in a phosphorylated state in the cytoplasm, whereas it is predominantly dephosphorylated in mature virions, suggesting that N function is regulated by phosphorylation (Wu et al.,
2009, 2014).
A major function of N is to encapsidate the ssRNA viral genome to evade immune detection and to protect
the viral RNA from degradation by host factors (Chang et al., 2014; McBride et al., 2014). N has two structural domains (Figure 1A): an N-terminal domain (NTD; amino acid residues 44–176) and a C-terminal
domain (CTD; amino acid residues 248–369). NTD is generally referred to as the RNA-binding domain,
although regions outside of NTD are implicated in RNA binding as well (Chang et al., 2014; Grossoehme
et al., 2009; Gui et al., 2017; Kang et al., 2020; McBride et al., 2014). NCTD exists as a dimer in solution and
can also bind RNA (Bouhaddou et al., 2020; Gui et al., 2017; Takeda et al., 2008). A conserved serine/arginine-rich linker region (LKR) connects the NTD and CTD (Figures 1A and S1A) (Chang et al., 2014). Phosphorylation of residues in the serine-arginine of the LKR is believed to regulate discontinuous transcription,
particularly for shorter subgenomic mRNA closer to the 30 end during early stages of replication (Wu et al.,
2009, 2014). The LKR along with residues at the extreme N and C termini (Narm: amino acid residues 1–43
and Carm: amino acid residues 370–419) are intrinsically disordered (Chang et al., 2014; Cubuk et al., 2021).
However, relative to the Narm and Carm, the LKR is more conserved (Figures 1B and S1B).
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Figure 1. Characterization of N oligomerization with dynamic light scattering
(A) Domain architecture of N. N has two structural domains: NTD and CTD. The sequence between NTD and CTD is a
linker region (LKR) containing a serine-arginine rich motif. The Narm, LKR, and Carm are predicted to be disordered
based on sequence analysis.
(B) Sequence identity between N of SARS-CoV-2, common cold coronaviruses, and other epidemic severe coronaviruses
MERS-CoV and SARS-CoV.
(C) Measurements of N oligomerization with DLS. Measured hydrodynamic radius, Rh, is reported in (D).
(D) Table summarizes the DLS data for all constructs. Numbers are reported as average and standard deviation of three
experiments.
See also Figures S1 and S2.

Given its abundant expression and conservation within the genome, N has been used as an antigen for
serology tests (Chew et al., 2020; Tang et al., 2020a, 2020b). Previous studies showed that N-specific antibodies dominate the overall antibody response (Hachim et al., 2020; Lu et al., 2021a). Furthermore, the
T cell responses directed toward N are highly immunodominant in SARS-CoV and SARS-CoV-2 infection,
with N-specific memory T cell responses evident 17 years after the initial SARS-CoV infection (Le Bert et al.,
2020). Thus, N protein stability, RNA-binding characteristics, abundance, and conservation are likely to
impact T and B cell immunity.
Previous studies, including our own, revealed shared and unique functions among viral nucleocapsid proteins (Arragain et al., 2019; Ding et al., 2016; Lu et al., 2021b; Luo et al., 2020; Raymond et al., 2010; Su et al.,
2018; Wan et al., 2017). These insights include oligomerization, RNA binding, and N-dependent functions
such as RNA synthesis and immune evasion. Here, we use a series of biochemical and biophysical assays to
dissect different regions in N to determine how oligomerization, RNA binding, and phosphorylation are
coupled to functions of N. Our results reveal that oligomeric N provides a continuous platform for binding
RNA with high affinity. Our hydrogen-deuterium exchange mass spectrometry (HDX-MS) data identified a
novel RNA-binding region within the LKR in addition to a positively charged patch within the NTD. We also
show that phosphorylation modulates N-RNA interactions and solution properties, including phase-separated droplets. Finally, we find that the CTD contributes to oligomerization and RNA binding, and is efficient at suppressing immune signaling. In SARS-CoV-2-infected patient plasma samples, the truncated
CTD of N provides a highly sensitive serological marker. Our studies add to the wealth of information
on SARS-CoV-2 N protein and expand upon our knowledge into N-domain-specific functions.

RESULTS
Multiple regions within N contribute to oligomerization
While several studies on SARS coronavirus N proteins report that N proteins oligomerize and that N oligomers are important for the assembly of viral particles (Chang et al., 2009; Luo et al., 2005; Ye et al., 2020), the
contribution of each N domain to oligomerization remains to be defined. To better understand the regions
within SARS-CoV-2 N important for promoting N-N interactions, we first used dynamic light scattering (DLS)
to determine the hydrodynamic properties of isolated, RNA-free N domains and combinations of domains.
Analysis of DLS results show that there are two major oligomeric species for full-length N (NWT; 46 kDa), with
hydrodynamic radii (Rh) of 8.9 nm and 450 nm (Figures 1C and 1D), suggesting the presence of different oligomeric forms of the protein. For comparison, the Rh values for maltose binding protein (44 kDa) and BSA
(66 kDa) are 2.9 nm and 3.7 nm, respectively. Removal of the Narm and Carm (NNTD-LKR-CTD) results in two
major species that are similar to NWT. However, both NNTD-LKR-CTD populations display reduced polydispersity (narrower peak width, Figure S2A), suggesting that both Narm and Carm contribute to N oligomerization. Further removal of the CTD (NNTD-LKR) results in a single peak representing a dimeric species (Rh =
3.9 nm), but with considerable polydispersity. NNTD and NCTD alone form stable domains; NNTD is a monomer (Rh = 2.3 nm), whereas NCTD is a dimer in solution (Rh = 3.5 nm), consistent with previous studies (Takeda
et al., 2008). Exact mass measurement by denaturing mass spectrometry yields values corresponding to the
mass expected from the amino acid sequence (G1 Da) and supports the identity of the constructs used here
(Figures S2B–S2E).

Oligomeric N provides a platform for high-affinity RNA binding
A critical function for N is to bind and encapsidate viral genomic ssRNA (Chang et al., 2014). This interaction
is sequence independent and as a result of N-RNA interactions, newly synthesized viral RNA often avoids
immune detection by cellular pattern recognition receptors (Leung and Amarasinghe, 2016). Previous
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Figure 2. SARS-CoV-2 nucleocapsid protein binds RNA with high affinity
(A) Fluorescence polarization assay to measure RNA binding. Increasing concentrations of N was titrated into 1 nM of
FITC-labeled RNA. Protein binding to FITC-RNA leads to slower tumbling of FITC-RNA, resulting in increased
fluorescence polarization.
(B) Fluorescence polarization binding curves of N constructs to a 20-nt ssRNA. The fitted KD values are 0.007 G 0.001 mM
(NWT, black square), 16 G 12 mM (NNTD, red circle), 13 G 5 mM (NCTD, blue up triangle), 0.006 G 0.002 mM (NNTD-LKR-CTD,
magenta down triangle), and 0.006 G 0.002 mM (NNTD-LKR-CTD-Carm, green diamond).
(C) Fluorescence polarization binding curves of N constructs with or without CTD to a 20-nt ssRNA. The fitted KD values
are 0.006 G 0.002 nM (NNTD-LKR-CTD, magenta down triangle), 13 G 5 mM (NCTD, blue circle), 0.50 G 0.08 mM (NNTD-LKR,
orange star), and 0.44 G 0.04 mM (NNTD-LKR + NCTD, purple pentagon).
(D) Fluorescence polarization binding curves of N constructs with or without NTD to a 20-nt ssRNA. The fitted KD values
are 0.006 G 0.002 mM (NNTD-LKR-CTD, magenta down triangle), 16 G 12 mM (NNTD, red circle), 0.35 G 0.04 mM (NLKR-CTD,
orange up triangle), and 0.72 G 0.09 mM (NNTD + NLKR-CTD, purple down triangle).
(E) Fluorescence polarization binding curves of N constructs to a slRNA. The fitted KD values are 0.051 G 0.004 mM
(NWT, black square), 124 G 84 mM (NNTD, red circle), 65 G 44 mM (NCTD, blue up triangle), 2.5 G 0.5 mM (NNTD-LKR,
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Figure 2. Continued
magenta down triangle), 0.22 G 0.02 mM (N NTD-LKR-CTD , green diamond), and 0.10 G 0.01 mM (N NTD-LKR-CTD-Carm , navy
left triangle).
(F) Table summarizes KD values (mM) for key constructs binding to ssRNA and slRNA. Numbers are reported as average
and standard deviation of two experiments. See also Figure S3.

results suggest that regions beyond the NTD are involved in RNA binding, but were limited by experimental detection and only select regions were characterized (Chang et al., 2009; Grossoehme et al.,
2009; Keane et al., 2012). To address this limitation and to gain insight into how each domain of SARSCoV-2 N contributes to RNA binding, we developed a sensitive fluorescence polarization assay to measure
binding of a fluorescein isothiocyanate (FITC)-labeled 20-nt ssRNA (sequence: UUUCACCUCCCUUUCAGUUU) (Figure 2A). From this assay, we find that NWT binds the 20-nt ssRNA with high affinity (KD =
0.007 G 0.001 mM). Removal of the Narm and Carm do not impact ssRNA binding (KD = 0.006 G 0.002
and 0.006 G 0.002 mM for NNTD-LKR-CTD-Carm and NNTD-LKR-CTD, respectively) (Figure 2B). In contrast, the isolated NNTD and NCTD have low-affinity binding (KD = 20 G 10 and 13 G 5 mM, respectively). However, inclusion of the LKR region increased RNA binding affinity significantly (0.50 G 0.08 and 0.35 G 0.04 mM
for NNTD-LKR and NLKR-CTD, respectively) (Figures 2B–2D). Addition of CTD onto NTD-LKR in cis increases
the binding affinity to the single-digit nM range (0.006 G 0.002 mM) (Figure 2C) but not in trans (compare
NNTD-LKR + NCTD with NNTD-LKR-CTD). The increase in binding affinity also occurs when NTD is added to LKRCTD in cis (Figure 2D, compare NLKR-CTD + NNTD with NNTD-LKR-CTD). Similar binding curves and KD values
were obtained when fluorescence polarization values were converted to anisotropy (Figure S3A). Collectively, our data quantitatively show that the NTD, CTD, and LKR each contribute to ssRNA binding and
that the presence of these three domains in tandem confers N with high-affinity RNA binding, suggesting
a more extensive and coupled RNA binding interface on N than is encompassed within a single domain.
N is proposed to disrupt dsRNA structures formed by transcription regulatory sequences during discontinuous transcription and impact viral RNA synthesis (Grossoehme et al., 2009; Keane et al., 2012; Sola et al.,
2015). To evaluate the impact of N binding to dsRNA structures, we used an RNA that forms a stable stemloop structure (slRNA) (sequence: GGAAGAUUAAUAAUUUUCC) (Figure 2E). We find that NWT binds this
slRNA with relative high affinity (KD = 0.051 G 0.004 mM), whereas both NNTD and NCTD alone have significantly weaker binding affinities (KD = 120 G 80 and 60 G 40 mM, respectively). Addition of LKR significantly
improves binding, consistent with results observed for ssRNA. Overall, slRNA binding to N appears to be at
an order of magnitude lower than to ssRNA binding (Figure S3B). This is potentially because, in part, of the
energetic penalty of unfolding the stem-loop structure. Furthermore, the Narm and Carm may contribute
more to slRNA binding than ssRNA because the impact on N binding is more pronounced after removal of
the Narm or Carm (Figure S3C).

HDX-MS defines an extended RNA-binding interface in N
X-ray crystal and NMR structures are available for the SARS-CoV-2 NNTD and NCTD as well as hybrid models
for RNA-bound NNTD (Dinesh et al., 2020; Kang et al., 2020; Ye et al., 2020). While these static structures
provide a wealth of information, a critical gap remains in our knowledge of N-RNA interactions. Our studies
here show that other N domains in cis contribute significantly to RNA binding. To further define the RNAbinding interface on N, we performed HDX-MS to locate regions that become protected upon RNA binding. We first tested the NNTD-LKR-CTD protein but observed aggregation on RNA binding that caused a 100fold loss in peptide abundances for the bound state, possibly attributable to aggregation-induced poor
digestion. To circumvent RNA-binding-induced protein aggregation, we reasoned that shorter constructs,
such as NNTD-LKR, could be used based on our binding studies. However, even for this shorter construct, we
noticed that the sample became cloudy after mixing with RNA. Next, given phosphorylation of N is a crucial
regulatory mechanism in the coronavirus life cycle (Wu et al., 2009), we hypothesized that N phosphorylation likely impacts N-RNA solution properties and stability. Therefore, we examined phosphomimics of N
for improved sample stability and solubility that are compatible with HDX-MS studies. For SARS-CoV,
glycogen synthase kinase (GSK)-3 was shown to phosphorylate N at Ser177 (corresponding to Ser176 in
SARS-CoV-2 N) (Wu et al., 2009). Phosphorylation of Ser177 is preceded by phosphorylation of Ser189
and Ser207 (Ser188 and 206 in SARS-CoV-2 N) by priming kinases (Wu et al., 2009). While more phosphorylation events may occur, we focused on these three better-known positions to evaluate if introduction of
S176D/S188D/S206D mutations into NNTD-LKR (NNTD-LKR S176D/S188D/S206D) will resolve N protein aggregation at the concentrations of interest.
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Figure 3. HDX-MS mapping of RNA binding to NNTD-LKR S176D/S188D/S206D
(A) Woods’ plot showing cumulative differential HDX and validating differences using global significance limits. The horizontal
bars depict the cumulative HDX differences between the RNA-bound and unbound NNTD-LKR S176D/S188D/S206D. Standard
deviations are shown for each peptide. Peptides showing statistically significant differences are differentiated by global
significance limit using the standard error of the mean and t-values for a two-tailed Student’s t-distribution (*, p < 0.1; **, p < 0.05;
***, p < 0.01). The blue shade of the peptide bar indicates differing statistical significance (green, light blue, and dark blue,
respectively); gray peptide bars depict peptides where statistically significant differences in HDX were not observed. Vertical bars
show previously reported binding sites (residues reported for RNA-binding CoV2 N-protein (Dinesh et al., 2020; Ye et al., 2020),
AMP-binding HCoV-OC43 (Lin et al., 2014; Ye et al., 2020), and for both are shown in red, yellow, and orange, respectively).
Secondary structure of SARS-CoV-2 NNTD (PDB 6M3M) is shown above.
(B) Representative kinetic plots showing peptide level HDX as a function of exchange time (unbound, black; bound to
RNA, red).
(C) Sites of protection measured by HDX mapped on the NNTD structure (PDB 6M3M). Statistically significant HDX
protection, regions of no difference in HDX, and regions where lacking proteolytic coverage results in no data are shown
in teal, light gray, and dark gray, respectively. Those residues unresolved in the structure are shown as a dashed line, with
the exception of those reporting a statistically significant difference in teal.
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Figure 3. Continued
(D) Electrostatic potential calculated with APBS mapped on to the NNTD structure (PDB 6M3M) shows a major positive
charge groove. Red and blue represent negative and positive electrostatic potential. The color scale is in kTe1 units. See
also Figure S4 and Mendeley data set (https://doi.org/10.17632/sv8r6phkzt.1).

With the introduction of the mutations on a shorter construct, NNTD-LKR S176D/S188D/S206D, we were able to
use sequential FXIII and pepsin digestion to recover 152 peptides, resulting in 93.3% sequence coverage
(Figure S4), which enabled us to further examine the system by HDX-MS. HDX-MS analysis of NNTD-LKR
S176D/S188D/S206D shows clear protection in four distinct regions on RNA binding (amino acid residues 41–
63, 105–108, and 146–171 in NTD, and 213–230 in LTR) (Figures 3A and 3B and Mendeley data set
https://doi.org/10.17632/sv8r6phkzt.1). Residues 133–143 are not perturbed by RNA binding, but peptides
covering residues 146–171 show clear protection. The largest differences in HDX are observed where 50–
80% of the residues of unbound peptides undergo a burst phase of HDX in the first 10 s (amino acid residues 146–156, 163–171, and 213–230), where the peptides cover regions of little hydrogen bonding in the
unbound state. When bound to RNA, the fraction of residues participating in the burst phase decreases,
resulting in observed protection. Then, HDX either converges over time (amino acid residues 146–156,
163–171, and 219–223) consistent with protein conformation or RNA binding dynamics or the HDX never
converges in the timescale of the experiment (amino acid residues 222–230), consistent with relatively static
binding. Interestingly, peptides covering amino acid residues 103–108 and 156–159 undergo very little
HDX throughout the experiment, consistent with either a hydrophobic pocket or secondary or tertiary
structure hydrogen bonding. Of note, HDX decreases for the bound state in these peptides only after 1
h. The low initial HDX limits the dynamic range of binding-induced protection from HDX, but statistically
significant protection is still observed.
Overall, HDX analysis revealed that the protected regions (Figure 3C) overlap with a basic patch groove
in the NNTD structure (Figure 3D) that is also observed in recently published NMR titration studies
(Dinesh et al., 2020); however, a region (amino acid residues 213–230) within the LKR domain, C-terminal to the SR-motif, also shows statistically significant HDX protection. This observation is consistent
with the C-terminal end of the LKR domain, a region truncated in other RNA-binding studies of
similar N proteins, being perturbed by RNA binding; furthermore, the parallel HDX kinetics plots
indicate relatively static binding interactions within this region. Interestingly, we did not detect HDX
protection in the SR-motif, which was proposed to bind RNA. This may be due to the Ser-to-Asp
mutations introduced into this region, changing the RNA binding patterns. Altogether, HDX results
along with our biochemical data define an RNA-binding interface within the NTD and LKR regions
of N.

N-RNA liquid droplet formation is impacted by N domains
The aforementioned oligomerization and RNA-binding results were obtained using RNA-free protein.
However, oligomerization is an intrinsic property of N and is complicated by RNA binding during copurification due to the high affinity of N proteins for RNA. We found that bacterial RNA copurified even with
increased ionic strength in purification buffer. Size-exclusion chromatography revealed three populations
of N, including two RNA-bound states (p1 and p2) and an RNA-free state (p3) (Figure 4A). Truncation of the
Narm results in an increase of the RNA-free peak (p3), suggesting that N truncations can alter the structure
of N and correspondingly impact RNA binding and oligomerization. When both Narm and Carm were
removed, we observed an even greater shift to p3, suggesting that both arms contribute to RNA-binding
interactions. To gain a better understanding of the two RNA-bound populations p1 and p2, we visualized
these samples using negative-stain electron microscopy in near-physiological salt concentrations
(150 mM). We observed that NWT p1 contains N-RNA with a loose-coil appearance (Figure 4B, top left),
similar to that observed for other RNA-bound Ns (Bharat et al., 2012; Mavrakis et al., 2002). In contrast,
we mostly observe spheres in NWT p2 that correspond to liquid droplets separated from the surrounding
buffer (Figure 4B, top right), consistent with many recent studies that describe liquid-liquid phase separation of N in the presence of RNA (Carlson et al., 2020; Cubuk et al., 2021; Iserman et al., 2020; Jack et al.,
2020; Savastano et al., 2020).
To determine if N regions that impact RNA binding also impact liquid droplet formation, we next examined the role of Narm and Carm. NNTD-LKR-CTD-Carm behaves similarly to NWT, having loose coils in p1
(Figure 4B, middle left) and forming spherical liquid droplets in p2 (Figure 4B, middle right). However,
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Figure 4. N-RNA forms liquid droplets and phosphorylation modulates N-RNA interactions
(A) Size exclusion chromatography of N constructs (NWT, black; NNTD-LKR-CTD-Carm, red; NNTD-LKR-CTD, blue) in 25 mM
HEPES, 500 mM NaCl, 2 mM TCEP, 5% glycerol. Samples from peak 1 (p1) and p2 contain RNA whereas p3 are RNA-free
based upon absorbance from the 260/280 ratio.
(B) Negative stain electron microscopy (EM) image of p1 (left panel) and p2 (right panel) for NWT, NNTD-LKR-CTD-Carm, and
NNTD-LKR-CTD in 150 mM NaCl. Samples were diluted into 150 mM NaCl before negative-staining fixation by uranyl
acetate.
(C) Size exclusion chromatography of N constructs (NWT, black; NS188D/S206D, blue; NS176D/S188D/S206D, red) in 25 mM
HEPES, 500 mM NaCl, 2 mM TCEP, 5% glycerol.
(D) Negative stain EM images of NS188D/S206D (top row) and NS176D/S188D/S206D (bottom row) in 150 mM NaCl.
(E) Fluorescence polarization binding curves of N mutants to a 20-nt ssRNA. The fitted KD values are 0.007 G 0.001 mM
(NWT, black square), 0.015 G 0.002 mM (NS176D/S188D/S206D, black circle), 0.505 G 0.075 mM (NNTD-LKR, orange up triangle),
and 1.1 G 0.2 mM (NNTD-LKR S176D/S188D/S206D, orange down triangle). Numbers are reported as average and standard
deviation of two experiments. See also Figure S5.

examination of p2 from NNTD-LKR-CTD (Figure 4B, bottom right) revealed a much smaller population
of liquid droplets (red arrow) and mostly crystal-like needle aggregates, suggesting that the Carm is
important for droplet formation. A transition from spherical liquids to needle-like solids is consistent
with the liquid-to-solid transitions observed for other proteins that undergo phase separation (Patel
et al., 2015).
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Figure 5. The CTD of N is a highly sensitive serological marker
(A) ELISA data of NWT screened against plasma of COVID-19 positive and negative individuals from a combined Hong Kong, PRC and St. Louis, MO, USA
cohort. Black solid line indicates the mean OD450 value for each population. ****p < 0.0001.
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(B) ELISAs with the various N constructs for patient IgG. ELISAs were performed on plasma samples from COVID-19 patients (n = 68) and negative controls
(n = 28). The cutoff is represented by the dotted line and calculated as the mean +3 standard deviations of the negative population. Mean values G standard
deviation of COVID-19 and negative groups are shown.
(C) Sensitivity and specificity for each of the N domains calculated from the ELISA results.
(D) Heatmap of ELISA results for NNTD-LKR-CTD-Carm, NCTD, and NNTD constructs from COVID-19 samples (n = 67). Each column represents an individual
sample.
(E) Maturation of the NCTD and NNTD-LKR-CTD-Carm IgG response over time (n = 67).
(F) Ratio of OD450 for NCTD and NNTD-LKR-CTD-Carm for acute and convalescent time points. Mean values G standard deviation of acute and convalescent
COVID-19 samples are shown. Experiments were repeated twice. Statistical significance was calculated by unpaired Student’s t-test, ****p < 0.0001.
(G) Inhibition of Sendai virus (SeV)-induced IFNb promoter activation by N constructs. Fold changes are relative to vector-only (V) transfections without SeV
infection. MLAV VP35 served as a positive control for inhibition. Three transfection concentrations were used: 1.25, 12.5, and 125 ng/well. Statistical
significance was determined by performing a one-way ANOVA followed with Tukey multiple comparison as compared to SeV-infected control; ****p < 0.0001,
***p < 0.0002, **p < 0.0021, *p < 0.0332.

Phosphorylation of LKR modulates RNA binding and higher-order assembly
Recently, N protein phosphorylation has been qualitatively shown to modulate both RNA binding and
phase separation (Carlson et al., 2020; Lu et al., 2021b; Savastano et al., 2020), and we successfully used
the improved solubility of phosphomimics to map the RNA binding interface within the NTD-LKR region.
To further test how phosphorylation quantitatively impacts RNA binding and solution properties of SARSCoV-2 N-RNA, we generated additional N phosphomimics in the context of NWT and NNTD-LKR. Size-exclusion chromatography showed that, compared with NWT, NS188D/S206D (priming serine residues for S176 by
GSK-3) produced a reduced RNA-free peak (p3) and an increased RNA-bound peak (p1) (Figure 4C). Introduction of S176D to generate NS176D/S188D/S206D resulted in an even greater shift in p1 and p3 distributions,
showing how phosphorylation can affect N interactions with RNA. The height of p2 remains relatively the
same for all preparations. Examination of these protein peaks using electron microscopy revealed that
NS188D/S206D displays similar loose coils in p1 (Figure 4D, top left) and spherical droplets in p2 (Figure 4D,
top right) for the RNA-bound species. Similar observations were made for NS176D/S188D/S206D (Figure 4D). To
describe this interaction further, we measured ssRNA binding to the N phosphomimics (Figures 4E and
S5A). NS176D/S188D/S206D displays 5-fold lower binding affinity to ssRNA compared with NWT binding, a
result in trend with previous work examining the impact of LKR phosphorylation on RNA binding through
simulations (Savastano et al., 2020). We observed a similar trend of lower binding to phosphomimics for the
NNTD-LKR construct. Furthermore, binding to slRNA is also affected by these mutations (Figure S5B). Collectively, our data suggest that phosphorylation of the LKR region can impact N interactions with RNA,
causing changes in properties, including solvent accessibility and RNA binding. Interestingly, there are
14 serine residues in the SR motif of LKR in SARS-CoV-2 N, of which 13 are found in SARS-CoV N, and
an increase in phosphorylation in this region may further enhance these changes for RNA interaction
and N associated functions.

NCTD is a sensitive serological marker
Given that the different domains of N impact the various biochemical and physicochemical properties of N,
we next assessed if particular domains contribute more significantly to N immunodominance that has been
observed worldwide (Hachim et al., 2020). Plasma samples collected from two cohorts of patients with realtime polymerase chain reaction (RT-PCR)-confirmed COVID-19, one in St. Louis, USA (n = 45) and one in
Hong Kong (n = 23), at different time points of infection. Using these samples, we performed enzymelinked immunosorbent assays (ELISAs) to detect IgG present in plasma of patients with COVID-19 using
different N domains that we have purified and characterized. First, we confirmed that purified NWT is a sensitive serological marker to differentiate between COVID-19-positive and COVID-19-negative individuals
(Figure 5A). As shown in Figure 5B, antibodies against all five N constructs were detected in the COVID19 cohort (p < 0.0001 versus negative controls for all). A cutoff based on the mean of the negatives plus
three standard deviations allowed us to assess the performance of each N construct at detecting IgG antibodies in COVID-19-positive individuals (Figure 5C). We find that NNTD-LKR-CTD-Carm shows the lowest
sensitivity (41.2%), whereas the truncated NNTD-LKR-CTD can detect more COVID-19-positive individuals
(70.6%). Furthermore, NCTD shows the highest combination of sensitivity (75%) and specificity (96.4%)
over the other N constructs tested. This is demonstrated by the lowest cutoff score for the NCTD for negative control samples, despite a comparable level of amino acid sequence conservation of the NCTD (29–
41%) to the NNTD (32–48%) and NLKR (28–42%) domains with common cold coronaviruses (Figure 1B).
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We next compared the immunogenicity of NNTD-LKR-CTD-Carm to NCTD and NNTD on an IgG heatmap during natural infection to an independent panel of 67 COVID-19 samples from Hong Kong. The magnitude of the IgG
response to the NNTD-LKR-CTD-Carm tends to follow the same trend as that of NCTD (Figure 5D). When we assessed
the kinetics of NCTD and the NNTD-LKR-CTD-Carm responses, we find that the magnitude of the NCTD IgG detection
tends to reach a similar level to that of NNTD-LKR-CTD-Carm at convalescent time points (after day 14) (Figure 5E).
The ELISA ratio of NCTD/NNTD-LKR-CTD-Carm demonstrates this finding, pointing to a maturation of the humoral
immune response toward the NCTD with time after infection (Figure 5F, p < 0.0001 for acute versus convalescent
time points). The early dominance of the NNTD-LKR-CTD-Carm IgG response may reflect the recruitment of a crossreactive preexisting N-specific response. This response becomes more specific with time for the NCTD domain
as a de novo antibody response is made.
Given that some RNA viral N proteins are known immune antagonists, including prior studies of SARS-CoV,
we hypothesized that N from SARS-CoV-2 may also suppress the type-I interferon (IFN) signaling pathway
(Messaoudi et al., 2015). Using an IFNb promoter reporter assay, we showed that N has a role in suppressing IFN signaling pathway when stimulated by Sendai virus (SeV) infection (Figure 5G). NWT can inhibit IFNb
promoter activity, although not as well as M
englà virus (MLAV) VP35, a potent inhibitor of IFN signaling
(Williams et al., 2020). Both NNarm-NTD-LKR and NNTD show modest inhibition at the highest concentration
tested. However, NCTD-Carm shows similar levels of inhibition as NWT, and NCTD displays the highest inhibition even at lower concentrations. In summary, N is a potent inhibitor of IFN signaling and the NCTD appears to be the region critical for mediating this function.

DISCUSSION
SARS-CoV-2 N protein is a core viral protein produced by the subgenomic RNA, positioned proximal to the
30 end of genome, displays high transcription levels, and is in high abundance in virions. N is prone to forming higher-order oligomers that is impacted by the presence of different domains. We found that the isolated NNTD and NCTD form well-behaved monomers and dimers, respectively. Linkage of the two domains
through the LKR and addition of the Narm and Carm contribute to N oligomerization, demonstrated in our
DLS studies. It also contributes to enhancement of RNA binding to a continuous platform that was quantitatively measured using a sensitive fluorescence polarization assay. Using HDX-MS for the NNTD-LKR phosphomimic, we confirmed a positively charged groove as an RNA-binding region in the NNTD but also revealed that unstructured regions flanking the SR motif in the LKR are important for RNA interactions,
which was not included in previous studies and crystal structures. The high extent of HDX observed for
the LKR domain in the absence of RNA is consistent with minimal hydrogen bonding (i.e., minimal defined
structure). Thus, with a lack of structural information from other techniques, RNA-induced decreased HDX
in the LKR domain could indicate RNA binding-induced secondary or tertiary structure, direct interactions
with the RNA, or oligomerization. Overall, these results demonstrate the functional importance of the LKR
domain for oligomerization and RNA binding. Thus, the coupling of oligomerization and RNA binding
likely provides multilayered regulation that is important for immune evasion, viral replication, and N
assembly.
N is also regulated by post-translational modifications and phosphorylation appears to play an important
role that modulates RNA binding and changes the physicochemical properties of N. Our data revealed that
mutation of S176, S188, and S206 in the SR motif to generate N phosphomimics resulted in decreased binding to RNA and a shift in protein-RNA populations with different solution properties.
In addition to characterizing the domain-specific biochemical and biophysical properties of N, we also
gained insight into the antigenicity of individual domains of N and their potential utility in serological
studies. Our data reveal that NCTD acts more specifically in detecting infection of SARS-CoV-2, from patient
plasma in comparison with NWT, consistent with predictions that the NCTD region encompasses major antigenic sites of N (Bussmann et al., 2006; Liang et al., 2005). Interestingly, 2 of 10 individuals assessed in this
study of longitudinal donors unexposed to SARS-CoV-2 by Edridge et al., produced broadly reactive antibodies toward SARS-CoV-2 NWT. The possibility of broadly reactive antibodies in unexposed individuals
highlights the need for domain-specific serology, such as our use of the NCTD for increased sensitivity to
discriminate COVID-19 cases, while reducing the false-positive rate from cross-reactive antibodies generated by infections of the common cold coronaviruses. Current serodiagnostic assays to identify COVID-19positive individuals are based on the detection of antibodies against N due to its abundant expression and
corresponding high immune response (Chew et al., 2020; Tang et al., 2020a, b). However, these N-directed
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serological assays are highly variable, and their sensitivity depend on the sampling time-points, ranging
from 0% to 93.75% (Liu et al., 2020; Tang et al., 2020a, b), suggesting that serological markers for SARSCoV-2 infection can be further improved to include the NCTD.
In conclusion, we describe our efforts to characterize how different domains contribute to the biochemical
and physicochemical properties of SARS-CoV-2 N. Our results advance the understanding of the different
levels of regulation involved in modulating viral replication and highlight the utility of using the NCTD as a
highly specific and sensitive diagnostic marker of COVID-19.

Limitations of the study
This study describes domain-specific insights into oligomerization, RNA binding, and phosphorylation of
SARS-CoV-2 N protein. Generated reagents were then used to demonstrate that NCTD is a more sensitive
and specific serology marker. However, the underlying mechanisms of how these biochemical properties
contribute to the observed immunodominance of the CTD of N are not clear and warrant further studies.

Resource availability
Lead contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by
the lead contact, Gaya Amarasinghe (gamarasinghe@wustl.edu).

Materials availability
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Data and code availability
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Plasmid pET28a-CterTEV His6 SARS-CoV-2 N 248-369

This work

N/A

Plasmid pCAGGS MLAV VP35

This work

N/A

Plasmid pCAGGS SARS-CoV-2 N 1-419

This work

N/A

Plasmid pCAGGS SARS-CoV-2 N 44-369

This work

N/A

Plasmid pCAGGS SARS-CoV-2 N 44-176

This work

N/A

Critical commercial assays
Dual-Glo luciferase kit
Experimental models: Cell lines
Human: HEK293T cells
Deposited data
HDX peptides table and kinetc plots
Oligonucleotides
20nt ssRNA sequence:
UUUCACCUCCCUUUCAGUUU
19nt slRNA sequence: GGAAGAUUAAUAAUUUUCC
Recombinant DNA

(Continued on next page)
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Continued

REAGENT or RESOURCE

SOURCE

IDENTIFIER

Plasmid pCAGGS SARS-CoV-2 N 248-419

This work

N/A

Plasmid pCAGGS SARS-CoV-2 N 248-369

This work

N/A

Department of Microbiology, Icahn School of

N/A

IFN-b promoter-firefly luciferase reporter plasmid

Medicine at Mount Sinai, New York, NY USA
pRL-TK Renilla luciferase reporter plasmid

Promega

E2231

Intact Mass

Protein Metrics Incorporated

Version 3.11

Byonic

Protein Metrics Incorporated

Version 3.11

Byologic

Protein Metrics Incorporated

Version 3.11

DataAnalysis v 4.4

Bruker Daltonics

Version 4.4

HDExaminer

Sierra Analytics Incorporated

Version 2.5.1

Origin

OriginLab

Version 7

UCSF Chimera

http://www.cgl.uscf.edu/chimera/

Version 1.14

PRISM

GraphPad

Version 7

Dynamics Software

Wyatt

Version 7

Gen5 Software

BioTek

Version 3

Software and algorithms

Other
ZORBAX Eclipse XDB C8 trap column (2.1 x 15 mm)

Agilent Technologies

Cat# 975700-936

XSelect CSH C18 XP (130 Å, 2.5 mm, 2.1 x 50 mm)

Waters Corporation

Cat# 186006101

MaXis II 4G Q-TOF

Bruker Daltonics

N/A

MaXis II HM Q-TOF

Bruker Daltonics

N/A

EmulsiFlex-C5 homogenizer

Avestin

N/A

Glow-Discharged Copper Grid, 200 mesh

Ted Pella

01840-F

JEM-1400 plus TEM

JEOL

N/A

Phosphor-Scintillated 12-bit CCD Camera

AMT

XR111

DynaPro-PlateReader II

Wyatt Technologies Corporation

N/A

Cytation5 Plate Reader

BioTek

N/A

EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human plasma
The collection of patient plasma was approved by the Human Research Protection Office at Washington
University in St. Louis (IRB reference number 202007097) and the Institutional Review Board of The Hong
Kong University and the Hong Kong Island West Cluster of Hospitals (IRB reference number UW20-169).

METHOD DETAILS
Patients and sample collection
Our study enrolled a total of 67 patients with RT-PCR-confirmed COVID-19 infection: with 45 patients from
St. Louis, MO, USA, and 23 patients from Hong Kong, PRC. The negative samples (n = 28) used in this study
were from St. Louis, USA, and were obtained from patients after the start of the pandemic. Plasma samples
were obtained from patients at Barnes-Jewish Hospital (St. Louis, MO, USA) and the Hong Kong Island
West Cluster of Hospitals (Hong Kong, PRC). Both hospital systems are urban, tertiary-care, academic medical centers. Positive and negative patients from all cohorts were confirmed using standard of care, RT-PCRbased methods. Plasma samples were collected from heparinized blood. Sample day was defined as days
after symptom onset.

Enzyme-linked immunosorbent assay
Enzyme-linked immunosorbent assays (ELISAs) were performed with N proteins made in house, as
described in the following. Briefly, recombinant N proteins were coated on 96-well flat-bottom
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immunosorbent plates (Nunc Immuno MaxiSorp) at a concentration of 500 ng/mL in 100 mL coating buffer
(phosphate-buffered saline [PBS] with 53% Na2CO3 and 42% NaHCO3, pH 9.6) at 4 C overnight. An additional plate coated with a nonspecific protein (blocking buffer, PBS with 5% fetal bovine serum (FBS)) was
used to measure the background binding of each plasma sample. After FBS blocking and thorough
washing, diluted plasma samples (1:100) were bound for 2 h, further washed, and then detected by an antihuman IgG secondary antibody labeled with HRP (Invitrogen), and absorbance detected at 450 nm on a
spectrophotometer (Wallac).

Protein expression and purification
SARS-CoV-2 N constructs were expressed as His-tag fusion proteins in BL21 (DE3) E. coli cells (Novagen). At
OD600 of 0.6-0.7, recombinant protein expression was induced with 0.5 mM isopropyl b-d-1-thiogalactopyranoside for 12–14 h at 18 C. Cells were harvested and resuspended in lysis buffer containing 20 mM Tris (pH
7.5), 1 M NaCl, 20 mM imidazole, 5 mM 2-mercaptoethanol (BME). Cells were lysed using an EmulsiFlex-C5
homogenizer (Avestin), and lysates were clarified by centrifugation at 30,000 x g at 4 C for 40 min. N proteins were purified using affinity tag and gel filtration columns. Purity of N proteins was determined by Coomassie staining of sodium dodecyl sulfate polyacrylamide gel electrophoresis. RNA-free species are used
for oligomerization, RNA binding, and ELISA studies.

Negative staining EM
Two microliter of N sample at a concentration of 1 mg/mL was applied to a glow-discharged copper grid
(Ted Pella), washed twice with water before staining with 2% uranyl acetate for 30 s, and air-dried. Grids
were imaged using a JEOL JEM-1400Plus Transmission Electron Microscope operating at 120 kV and recorded with an AMT XR111 high-speed 4k x 2k pixel phosphor-scintillated 12-bit CCD camera.

Dynamic light scattering
Dynamic light scattering experiments were performed on a DynaPro-PlateReader II (Wyatt Technologies
Corporation). Measurements of N samples in triplicates (1 mg/mL) were obtained at 25 C and analyzed using Dynamics software (Wyatt).

Fluorescence polarization assay
Fluorescence polarization assay experiments were performed on a Cytation5 plate reader (BioTek) operating on Gen5 software. Excitation and emission wavelengths were set to 485 and 528 nm, respectively,
with a bandpass of 20 nm. Read height and G factor were set to 8.5 mm and 1.26, respectively, using
the autogain function. For RNA-binding experiments, fluorescein-isothiocyanate-labeled 20-nt ssRNA or
19-nt slRNA at a final concentration of 1 nM was loaded on N samples (in 20 mM HEPES (pH 7.5),
150 mM NaCl, 2 mM TCEP, 5% glycerol) at concentrations ranging from 0.4 nM to 10 mM in a 96-well plate.
After 10 min of incubation, fluorescence polarization signals were read. The fluorescence polarization
values were then plotted against N concentrations to fit the dissociation constant, KD, using ORIGIN software. For anisotropy plots, anisotropy values were converted from polarization as per previous research
(Kozlov et al., 2012).

Liquid chromatography-tandem mass spectrometry analysis
Unless otherwise indicated, all chemical reagents were sourced from Millipore Sigma and used without
further purification. For liquid chromatography-tandem mass spectrometry (LC-MS) analyses, 30 pmol of
protein in 50 mL of 1:1 solvent mixture of acetonitrile:water with 0.1% formic acid (CovaChem) was loaded
onto a C8 trap (ZORBAX Eclipse XDB C8 column, 2.1 x 15 mm, Agilent), desalted for 3 min by using water/
0.1% formic acid at a flow rate of 100 mL/min, and eluted using an 14 minute gradient from 0 to 80% acetonitrile/0.1% formic acid at a flow rate of 100 mL/min. Samples were analyzed using a MaXis 4G Q-TOF
(Bruker Daltonics). The mass spectrum was extracted, guided by the elution peak and submitted to PMI
Intact Mass and searched for M values ranging from 5 to 50 kDa.

HDX-MS
NNTD-LKR S176D/S188D/S206D was incubated with a 20-nt ssRNA at a 1:1 ratio. After incubation, 2 mL of 50 mM
protein/protein-RNA in PBS (pH 7.4) was diluted 10 times (v/v) with labeling buffer (PBS in D2O, pD 7.0)
(D2O from Cambridge Isotope Laboratories), incubated for 10, 30, 300, and 3600 s on ice, quenched by using
a 60% dilution with 3 M urea, PBS (pH 2.5), and flash frozen for later LC-MS analysis. A 0 s control was
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prepared with PBS in H2O. Before incubation, each 50 mL of 2 mM sample was thawed for 1 min at 37 C before
injection into a custom-built liquid chromatography apparatus for LC-MS analysis. The labeled protein
passed through two in-house packed protease columns (2 mm x 20 mm), coupled so that the first using protease from Aspergillus saitoi type XIII (FXIII) and the second porcine pepsin (0.1% formic acid, flow rate
200 mL/min); the resulting peptides were trapped on a ZORBAX Eclipse XDB C8 column (2.1 mm x
15 mm, Agilent), desalted for 3 min, and then separated on a XSelect CSH C18 XP column (130Å, 2.5 mm,
2.1 mm X 50 mm, Waters) with a 10.5 min linear gradient from 4 – 40% acetonitrile/0.1% formic acid (flow
rate 100 mL/min). All valves, tubes, and columns (except for the protease columns, which lose activity at
low temperature) were submerged in ice during the experiment to minimize back exchange. Peptides
were eluted into a Bruker Maxis HM Q-TOF MS for mass analysis. Experiments were in duplicate unless
otherwise indicated. The HDX data processing was performed by using HDExaminer (version 2.5.1, Sierra
Analytics, Inc.).

IFNb promoter reporter gene assay
HEK-293T cells (5 x 104) were cotransfected using Lipofectamine 2000 with 25 ng of an IFNb promoter-firefly
luciferase reporter plasmid, 25 ng of pRL-TK Renilla luciferase reporter plasmid, and 125, 12.5, and 1.25 ng
of the indicated viral protein expression plasmid. Twenty-four hours after transfection, cells were mocktreated or SeV (15 hemagglutination units/mL) infected. Eighteen hours after treatment or after infection,
cells were lysed and analyzed for luciferase activity using a Dual-Luciferase reporter assay system (Promega). Firefly luciferase activity was normalized to Renilla luciferase activity. Assays were performed in triplicate; error bars indicate the standard error of the mean (SEM) for the triplicate. Viral protein expression
was confirmed by Western blot analysis.

QUANTIFICATION AND STATISTICAL ANALYSIS
All HDX samples for each time point were prepared and acquired in duplicate. HDX results for peptides with
m/z peaks interfering/overlapping with the theoretical centroid fit were excluded from the analysis. Error
bars in the kinetic plots show the standard deviation for each protein state and time point. Error bars shown
in the Woods’ plot are 3 times the propagated error for each peptide across all time points (if the error bar
does not cross zero, then the difference is potentially significant). The global significance limit (i.e., the minimum difference in number of deuterium for a statistically significant difference) is shown in gray. Briefly, we
first calculated the pooled standard deviation for each state, using standard deviations for all peptides and
all time points (n = 214 peptides x 4 states = 856 total data points for each state). From the pooled standard
deviations of each state, the SEM was calculated for the entire data set (n = 2 replicates). The global significance limit is then the confidence interval using this SEM t-values for a two-tailed Student’s t-distribution
(*, p < 0.1; **, p < 0.05; ***, p < 0.01, 2 degrees of freedom [2 states + 2 replicates – 2]). In the Woods’
plot, peptide HDX differences are considered significant if the difference exceeds this limit. Peptides are
only considered statistically significant if both the conditions for the propagated error and the global significance limit are met.
For ELISA data, the cutoff is represented by the dotted line and calculated as the mean + 3 standard deviations of the negative population, used to calculate sensitivity and specificity. Experiments were repeated
twice. Statistical significance was calculated by unpaired Student’s t-test using GraphPad Prism.
For IFN-b promoter assay, statistical significance was determined by performing a one-way ANOVA followed with Tukey multiple comparison as compared to Sendai-virus-infected control using GraphPad
Prism.
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